Account
Inquiry
Tirzepatide 20mg is a high-purity peptide compound developed for research applications in diabetes and metabolic studies. This white powder formulation contains the dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist known for its potential in type 2 diabetes research.
The molecular structure of tirzepatide 20mg (C225H348N48O68) features a lysine side chain with PEG modification, enhancing water solubility while maintaining biological activity. Research indicates this compound demonstrates superior efficacy in glucose control compared to selective GLP-1 receptor agonists alone.
Clinical studies with tirzepatide 20mg have shown significant potential in weight management applications, with trial participants demonstrating substantial weight reduction over 72-week periods. The compound's dual agonist mechanism appears to enhance metabolic effects beyond single-pathway medications.
Our tirzepatide 20mg is supplied in pharmaceutical-grade purity (99.9%) for research use only. The product undergoes rigorous quality control testing to ensure batch-to-batch consistency and reliable performance in laboratory settings.
Storage recommendations include maintaining the tirzepatide 20mg powder in cool, dry conditions protected from light exposure. Researchers should aliquot the material according to experimental requirements to minimize freeze-thaw cycles.
As a research chemical, tirzepatide 20mg represents an important tool for investigating novel diabetes treatments and metabolic regulation pathways. The compound's unique dual-receptor activity profile makes it particularly valuable for comparative pharmacological studies.
